Micronutrient Deficiencies on GLP-1 Inhibitors Individuals taking GLP-1 inhibitors may be at risk for certain micronutrient deficiencies, primarily due to reduced appetite leading to lower food intake
Abbreviations ACS: acute coronary syndrome CV: cardiovascular GLP-1RA: glucagon-like peptide-1 receptor agonist DPP-4: dipeptidyl peptidase-4 HF: heart failure MACE: major adverse CV event SGLT2: sodium-glucose cotransporter 2 T2D: type 2 diabetes References Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, et al
GLP BodyGuard's brand-stated positioning - educational tracking, not medical advice, not diagnosis, not treatment - is structurally consistent with what the FDA's 2026 guidance describes as general wellness territory
& Kaarniranta, K
Mechanisms of Coronary Artery Spasm
These conditions include: Kidney disease Liver problems Electrolyte abnormalities Diabetes Low blood volume Overdose A spironolactone overdose can be fatal, but the median lethal dose is extremely high, far greater than the maximum recommended dose of 400 mg per day